Status:
COMPLETED
Siemens 3-D C-Arm CT of the Heart Chambers
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
Siemens Medical Solutions
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the optimal images of the heart structures which are used to guide AF ablation or BiVenticle and coronary vessels.
Detailed Description
'Atrial fibrillation (AF) and ventricular fibrillation are common sustained arrhythmias. The patient will be given an intravenous contrast dye and then hold their breath for 15 seconds while pictures ...
Eligibility Criteria
Inclusion
- Patients undergoing EP diagnostic or therapeutic procedure
- Age \> 18 years
- Male or Female
- Weight \< 250 lbs
- Not pregnant - women without childbearing potential or women consenting to a pregnancy test
- Able to hold breath for a maximum of 15 seconds
- Sufficient kidney function to support a maximum of 200 cc of contrast in addition to whatever contrast will be given during the EP Procedure
- Creatinine \< 1.7 AND cleared by physician prior to case
- Implantable foreign objects acceptable
- NSR or AF
- Patient must sign an informed consent
Exclusion
- Patients should not have undergone a CT or CTA scan in the 24 hours prior to this study.
- Creatinine (GFR value) greater than 60
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00619450
Start Date
August 1 2007
End Date
September 1 2008
Last Update
February 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195